Evidence map›Paper›PMID 32354799›Full record

ArticleHeart (British Cardiac Society)2020

COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander?

Richard Cheng, Douglas Leedy

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Heart (British Cardiac Society), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Stroke in COVID-19: A systematic review and meta-analysis.International journal of stroke : official journal of the International Stroke Society · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Prognostic significance of CHADSJournal of cardiovascular and thoracic research · 2022
    Article
  11. Venous and arterial thromboembolic disease in COVID-19.Journal of thrombosis and thrombolysis · 2021
    Article
  12. Key Characteristics of Cardiovascular Toxicants.Environmental health perspectives · 2021
    Article
  13. Prevalence and Prognostic Value ofJournal of clinical medicine · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2021
    Article
  19. SARS-CoV-2 and the cardiovascular system.Clinica chimica acta; international journal of clinical chemistry · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Richard ChengDepartment of Medicine, Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA rkcheng@uw.edu.ORCID 0000-0001-5994-5998
Douglas LeedyDepartment of Medicine, Division of Cardiology, University of Washington Medical Center, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusCOVID-19HeartHumansPrognosisSARS-CoV-2acute myocardial infarctionmyocardial disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.